Provided by Tiger Fintech (Singapore) Pte. Ltd.

InVivo Therapeutics

0.3207
+0.0000
Volume:- -
Turnover:- -
Market Cap:995.92K
PE:-0.09
High:0.3207
Open:0.3207
Low:0.3207
Close:0.3207
Loading ...
Nov 02, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 20, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 16, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 07, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 05, 2020

Major Issues Report

8-K - Current report
Jun 02, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 22, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Apr 24, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Apr 24, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Apr 16, 2020

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Apr 16, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 16, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 11, 2020

Major Issues Report

Current report, items 8.01 and 9.01